We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

27 hedge funds and large institutions have $1.9M invested in Dare Bioscience in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

29% more funds holding

Funds holding: 21 → 27 (+6)

0.58% less ownership

Funds ownership: 7.49% → 6.9% (-0.58%)

12% less capital invested

Capital invested by funds: $2.16M → $1.9M (-$254K)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
27
Holders Change
+6
Holders Change %
+28.57%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$256K
2
Two Sigma Investments
Two Sigma Investments
New York
+$65.9K
3
US Bancorp
US Bancorp
Minnesota
+$41.7K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$35.7K
5
LPL Financial
LPL Financial
California
+$29.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$79K
2
HighTower Advisors
HighTower Advisors
Illinois
-$24.6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$9.41K
4
GRP
Global Retirement Partners
California
-$9.15K
5
UBS Group
UBS Group
Switzerland
-$3.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.01M +$256K +128,156 +32%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$229K -$9.41K -4,718 -4%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$135K +$19.6K +9,800 +16%
Two Sigma Investments
4
Two Sigma Investments
New York
$63.8K +$65.9K +33,036 New
State Street
5
State Street
Massachusetts
$45.4K – – –
US Bancorp
6
US Bancorp
Minnesota
$40.4K +$41.7K +20,920 New
UBS Group
7
UBS Group
Switzerland
$40.4K -$3.4K -1,706 -8%
Renaissance Technologies
8
Renaissance Technologies
New York
$37.2K -$79K -39,600 -67%
VF
9
Virtu Financial
New York
$37K +$2.91K +1,460 +8%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$34.5K +$35.7K +17,900 New
BlackRock
11
BlackRock
New York
$32.8K – – –
Northern Trust
12
Northern Trust
Illinois
$29.8K +$920 +461 +3%
Raymond James Financial
13
Raymond James Financial
Florida
$29.6K – – –
LPL Financial
14
LPL Financial
California
$28.3K +$29.2K +14,639 New
XT
15
XTX Topco
Cayman Islands
$21.2K +$21.9K +10,983 New
OS
16
Objectivity Squared
South Carolina
$21.1K +$21.8K +10,915 New
Jane Street
17
Jane Street
New York
$20.4K +$21.1K +10,559 New
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$20K – – –
HF
19
HRT Financial
New York
$20K +$20.9K +10,497 New
PA
20
Parallel Advisors
California
$4.64K +$4.8K +2,405 New
IA
21
IFS Advisors
Kansas
$1.83K – – –
SS
22
SBI Securities
Japan
$1.11K -$2 -1 -0.2%
Bank of America
23
Bank of America
North Carolina
$250 -$4 -2 -2%
TRCT
24
Tower Research Capital (TRC)
New York
$212 +$220 +110 New
CSC
25
Caldwell Sutter Capital
California
$33 – – –
1
2

DARE Hedge Fund Activity: Q4 2025 in Review

27 of the 8,231 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2025, worth a combined $1.9M — down 12% from $2.16M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new DARE positions and 4 closed out — a net gain of 7 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $256K. The largest seller was Renaissance Technologies, cutting an estimated $79K.

  • 27 institutional investors held Dare Bioscience (DARE) as of Q4 2025, up from 21 in Q3 2025.
  • Funds reported $1.9M of Dare Bioscience stock for Q4 2025, down 12% quarter-over-quarter.
  • 11 funds opened new Dare Bioscience positions in Q4 2025 and 4 closed out, a net change of +7 holders.
  • The largest Dare Bioscience buyer in Q4 2025 was Vanguard Group, an estimated $256K added.
  • The largest Dare Bioscience seller in Q4 2025 was Renaissance Technologies, an estimated $79K sold.

Based on aggregated 13F filings for Q4 2025.